Previous
Previous

PCCTC Scientific Oversight Committee Chair Reflects on Advances Made in High-Risk, Low-Grade Prostate Cancer Management

Next
Next

Results from the PCCTC’s Randomized Phase 2 Trial of Abiraterone Acetate With or Without Cabazitaxel Published in The Journal of Clinical Oncology